Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hearing Tests × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Ototoxicity 1 Neoplasms 1 Hearing Loss 1

Interventions

pembrolizumab 83 Cyclophosphamide 56 Cisplatin 51 Nivolumab 41 Gemcitabine 33 Paclitaxel 32 Carboplatin 31 Radiotherapy 29 Dexamethasone 28 fludarabine 27 Blood Specimen Collection 27 Doxorubicin 20 Rituximab 18 Lenalidomide 18 Ipilimumab 18 Fluorouracil 18 Docetaxel 18 atezolizumab 17 Prednisone 17 Oxaliplatin 17 Irinotecan 17 Cetuximab 17 Trastuzumab 16 Surveys and Questionnaires 16 Biopsy 16 lenvatinib 15 durvalumab 15 Vincristine 15 Leucovorin 15 Cytarabine 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06036407 2026-04-14

HEAR

University of Bern

Phase NA Completed

Ototoxicity, Neoplasms, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡